Potential drugs used in the antibody–drug conjugate (ADC) architecture for cancer therapy - Yaghoubi - 2020 - Journal of Cellular Physiology - Wiley Online Library
Pharmaceuticals | Free Full-Text | Antibody–Drug Conjugates: The Last Decade | HTML
On the use of DNA as a linker in antibody-drug conjugates: synthesis, stability and in vitro potency | Scientific Reports
CHAPTER 1 Introduction to Antibody–Drug Conjugates (ADCs) (RSC Publishing) DOI:10.1039/9781788012898-00001
Optimal design, anti-tumour efficacy and tolerability of anti-CXCR4 antibody drug conjugates | Scientific Reports
Antibody-Drug Conjugates: The New Frontier of Chemotherapy
Bioprocess development of antibody-drug conjugate production for cancer treatment
Kadcycla ADC - Potency Regulatory and Bioprocessing Concerns of ADCs - BioProcess InternationalBioProcess International
Proof of site-specificity of antibody-drug conjugates produced by chemical conjugation technology: AJICAP first generation - ScienceDirect